Who is sponsoring Mousquetaires?

Mousquetaires is sponsored by Société Française d'Endoscopie Digestive.

What condition does Mousquetaires study?

Mousquetaires studies Pancreatic Tumor, Puncture.

What drugs are being tested in Mousquetaires?

Interventions: EUS-FNB with 20-gauge Procore® needle, EUS-FNB with 22-gauge Acquire® needle.

What is the status of Mousquetaires?

Mousquetaires is currently COMPLETED.

Last reviewed 2018-02-23 · How we verify

Comparison of Two Endoscopic Biopsic Needles for Pancreatic Tumors (Mousquetaires)

NCT03444051 COMPLETED

This observational study compared quality of histological sampling of pancreatic EUS-FNB with the 20-gauge Procore® and 22-gauge Acquire® needles. In total, 68 patients were recruited. Histological diagnosis was achieved and a histological core biopsy was obtained in 82% of patients (28/34) in the 20-gauge Procore® group and 97% of patients (33/34) in the 22-gauge Acquire® group (P=0.1). Core biopsy specimens obtained were significantly longer with the 22-gauge Acquire® needle with a mean cumulative length of tissue core biopsies per needle pass of 4,33±3,46mm vs. 7,9±4,35mm for the 20-gauge Procore® (P\<0,01). Reproducibility of this simple histological criterion was validated in intra and inter-observer.

Details

Lead sponsor	Société Française d'Endoscopie Digestive
Status	COMPLETED
Enrolment	68
Start date	Wed Mar 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Pancreatic Tumor
Puncture

Interventions

EUS-FNB with 20-gauge Procore® needle
EUS-FNB with 22-gauge Acquire® needle

Countries

France